A Study of RSLV-132 in Females With Sjögren's Disease

Clinical trial NCT06440525 · RECRUITING

Trial details

NCT number: NCT06440525
Sponsor: Resolve Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sjögren Syndrome

Start date: 2024-12-01
Primary completion: 2026-12-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.